Clinical Trial Update: A Clinical Trial for CTD-ILD Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial for connective tissue disease-associated interstitial lung disease (CTD-ILD) sponsored by the University of Michigan was terminated, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease
• Interstitial Lung Disease

Snippet

Sponsor: University of Michigan | Conditions: Interstitial Lung Disease, Connective Tissue Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2016-02-12